4.7 Article

Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CLProtease Inhibitor Clinical Candidate for Treating COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Medicinal

Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLPro)

Sang Hoon Han et al.

Summary: Starting from ML300, a structure-based optimization campaign was conducted against the SARS-CoV-2 main protease, resulting in the discovery of compound 41 with antiviral activity. This study provides important insights for the development of antiviral drugs in combating SARS-like coronavirus outbreaks.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Crystallography

What is This? A Structure Analysis Tool for Rapid and Automated Solution of Small Molecule Structures

Takashi Matsumoto et al.

Summary: Researchers have proposed a new tool called WIT, which achieves fully automated crystal structure analysis to bridge the gap between traditional SC-XRD and MicroED methods. This method provides molecular structures with sufficient quality at a faster rate, showing great potential for various applications.

JOURNAL OF CHEMICAL CRYSTALLOGRAPHY (2021)

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Microbiology

SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

Michihito Sasaki et al.

Summary: This study identified SARS-CoV-2 variants with mutations at the cleavage motif of the S protein (S gene mutants) that undergo inefficient proteolytic cleavage, leading to smaller plaques and less infectivity. These mutants emerged rapidly through virus propagation in Vero cells and may have been unknowingly used in experiments, antiviral screenings, and vaccine development. The mutations affect the virus' entry pathway and cell tropism, emphasizing the importance of monitoring de novo S gene mutations during tissue-culture propagation.

PLOS PATHOGENS (2021)

Article Multidisciplinary Sciences

An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen et al.

Summary: PF-07321332, an orally bioavailable SARS-CoV-2 main protease inhibitor, has been discovered with in vitro pan-human coronavirus antiviral activity and excellent off-target selectivity and in vivo safety profiles. This new drug has shown promise in countering the threat of COVID-19 with its oral activity and safety in clinical trials.

SCIENCE (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model

Jingxin Qiao et al.

Summary: The study designed and synthesized 32 new M-pro inhibitors containing bicycloproline, which showed inhibitory effects on SARS-CoV-2. Compounds MI-09 and MI-30 exhibited excellent antiviral activity in cell-based assays and significantly reduced lung viral loads and lung lesions in a transgenic mouse model of SARS-CoV-2 infection. Both also displayed good pharmacokinetic properties and safety in rats.

SCIENCE (2021)

Review Pharmacology & Pharmacy

Potency, Safety, and Pharmacokinetic Profiles of Potential Inhibitors Targeting SARS-CoV-2 Main Protease

Hylemariam Mihiretie Mengist et al.

Summary: The review highlights the potency, safety, and pharmacokinetic profiles of potential inhibitors targeting SARS-CoV-2 M-pro, emphasizing the need for further research in COVID-19 therapeutics.

FRONTIERS IN PHARMACOLOGY (2021)

Editorial Material Chemistry, Multidisciplinary

Potent SARS-CoV-2 Direct-Acting Antivirals Provide an Important Complement to COVID-19 Vaccines

Stephen Pelly et al.

ACS CENTRAL SCIENCE (2021)

Article Immunology

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

Ruoke Wang et al.

Summary: Research shows that the South African B.1.351 variant exhibits the highest resistance to current monoclonal antibodies and convalescent plasma from COVID-19-infected individuals, and the molecular basis for this resistance and potential antibody escape has been identified.

IMMUNITY (2021)

Article Multidisciplinary Sciences

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Chamandi S. Dampalla et al.

Summary: The study presents a series of deuterated 3CLpro inhibitor variants, particularly GC376, showing potent antiviral effects against SARS-CoV-2 in cell-based and enzyme assays. Treatment with a deuterated derivative of GC376 increased survival rates in lethally infected mice and reduced lung virus titers and histopathological changes. Structural investigation revealed promising potential of deuterated GC376 variants as effective antiviral agents against SARS-CoV-2 through their binding interactions with 3CLpro.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin et al.

NATURE (2020)

Article Chemistry, Medicinal

The SARS-CoV-2 main protease as drug target

Sven Ullrich et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

Article Multidisciplinary Sciences

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Alice Douangamath et al.

NATURE COMMUNICATIONS (2020)

Review Chemistry, Medicinal

Proteases and protease inhibitors in infectious diseases

Ayodeji A. Agbowuro et al.

MEDICINAL RESEARCH REVIEWS (2018)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Article Multidisciplinary Sciences

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

V. Stalin Raj et al.

NATURE (2013)

Article Biochemical Research Methods

Features and development of Coot

P. Emsley et al.

ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)

Article Biochemistry & Molecular Biology

Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution

Jeremy R. Greenwood et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)

Article Chemistry, Multidisciplinary

Combining docking with pharmacophore filtering for improved virtual screening

Megan L. Peach et al.

JOURNAL OF CHEMINFORMATICS (2009)

Article Biochemistry & Molecular Biology

Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules

John C. Shelley et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)

Article Biochemistry & Molecular Biology

PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results

Steven L. Dixon et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)

Article Biochemistry & Molecular Biology

PHASE: A novel approach to pharmacophore modeling and 3D database searching

Steven L. Dixon et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2006)

Article Biochemistry & Molecular Biology

Design of wide-spectrum inhibitors targeting coronavirus main proteases

HT Yang et al.

PLOS BIOLOGY (2005)

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

RA Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)

Article Chemistry, Medicinal

Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening

TA Halgren et al.

JOURNAL OF MEDICINAL CHEMISTRY (2004)